These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7924765)

  • 1. Effects of labetalol on cocaine pharmacokinetics in neonatal piglets.
    Scalzo FM; Primozic S; Burge LJ; Badger TM; Creer MH; Nehus C; Karba R
    Dev Pharmacol Ther; 1993; 20(1-2):54-63. PubMed ID: 7924765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-response cocaine pharmacokinetics and metabolite profile following intravenous administration and arterial sampling in unanesthetized, freely moving male rats.
    Booze RM; Lehner AF; Wallace DR; Welch MA; Mactutus CF
    Neurotoxicol Teratol; 1997; 19(1):7-15. PubMed ID: 9088006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cocaine, norcocaine, ecgonine methylester and benzoylecgonine pharmacokinetics in the rat.
    Mets B; Diaz J; Soo E; Jamdar S
    Life Sci; 1999; 65(12):1317-28. PubMed ID: 10503947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of labetalol in the pregnant sheep.
    Yeleswaram K; Rurak DW; Hall C; Wright MR; Axelson JE
    J Pharmacol Exp Ther; 1992 Aug; 262(2):683-91. PubMed ID: 1501116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous pharmacokinetic modeling of cocaine and its metabolites, norcocaine and benzoylecgonine, after intravenous and oral administration in rats.
    Sun L; Lau CE
    Drug Metab Dispos; 2001 Sep; 29(9):1183-9. PubMed ID: 11502725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of infused catecholamines on the pharmacokinetics of cocaine and benzoylecgonine formation after bolus dose or continuous cocaine administration in the rat.
    Mets B; Jamdar S; Diaz J
    J Pharm Pharmacol; 1999 Jun; 51(6):679-84. PubMed ID: 10454044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuation of the systemic and coronary hemodynamic effects of cocaine in conscious dogs: propranolol versus labetalol.
    Kenny D; Pagel PS; Warltier DC
    Basic Res Cardiol; 1992; 87(5):465-77. PubMed ID: 1334401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics and kinetic-dynamic relationships of dilevalol and labetalol.
    Donnelly R; Macphee GJ
    Clin Pharmacokinet; 1991 Aug; 21(2):95-109. PubMed ID: 1884570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of inhibition of plasma cholinesterase and hepatic microsomal enzyme activity on cocaine, benzoylecgonine, ecgonine methyl ester, and norcocaine blood levels in pigs.
    Kambam J; Mets B; Hickman RM; Janicki P; James MF; Fuller B; Kirsch RE
    J Lab Clin Med; 1992 Aug; 120(2):323-8. PubMed ID: 1500830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and effect of cocaine on cerebral blood flow in the newborn.
    Anday EK; Lien R; Goplerud JM; Kurth CD; Shaw LM
    Dev Pharmacol Ther; 1993; 20(1-2):35-44. PubMed ID: 7924763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioavailability and Pharmacokinetics of Oral Cocaine in Humans.
    Coe MA; Jufer Phipps RA; Cone EJ; Walsh SL
    J Anal Toxicol; 2018 Jun; 42(5):285-292. PubMed ID: 29462364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transplacental pharmacokinetics and maternal/fetal plasma concentrations of cocaine in pregnant macaques near term.
    Binienda Z; Bailey JR; Duhart HM; Slikker W; Paule MG
    Drug Metab Dispos; 1993; 21(2):364-8. PubMed ID: 8097710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the clinical pharmacokinetics and concentration-effect relationships for medroxalol and labetalol.
    Elliott HL; Meredith PA; Sumner DJ; Reid JL
    Br J Clin Pharmacol; 1984 May; 17(5):573-8. PubMed ID: 6145441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of food on the oral and intravenous pharmacokinetics of a high clearance drug: a study with labetalol.
    Daneshmend TK; Roberts CJ
    Br J Clin Pharmacol; 1982 Jul; 14(1):73-8. PubMed ID: 7104169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elimination of cocaine and metabolites in plasma, saliva, and urine following repeated oral administration to human volunteers.
    Jufer RA; Wstadik A; Walsh SL; Levine BS; Cone EJ
    J Anal Toxicol; 2000 Oct; 24(7):467-77. PubMed ID: 11043648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in adrenoceptors and monoamine metabolism in neonatal and adult rat brain after postnatal exposure to the antihypertensive labetalol.
    Erdtsieck-Ernste EB; Feenstra MG; Botterblom MH; De Barrios J; Boer GJ
    Br J Pharmacol; 1992 Jan; 105(1):37-44. PubMed ID: 1596689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cocaethylene metabolism and interaction with cocaine and ethanol: role of carboxylesterases.
    Laizure SC; Mandrell T; Gades NM; Parker RB
    Drug Metab Dispos; 2003 Jan; 31(1):16-20. PubMed ID: 12485948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of labetalol treatment on the physiological and subjective response to smoked cocaine.
    Sofuoglu M; Brown S; Babb DA; Pentel PR; Hatsukami DK
    Pharmacol Biochem Behav; 2000 Feb; 65(2):255-9. PubMed ID: 10672977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct nose-brain transport of benzoylecgonine following intranasal administration in rats.
    Chow HH; Anavy N; Villalobos A
    J Pharm Sci; 2001 Nov; 90(11):1729-35. PubMed ID: 11745730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cocaine pharmacokinetics in the pregnant guinea pig.
    Sandberg JA; Olsen GD
    J Pharmacol Exp Ther; 1991 Aug; 258(2):477-82. PubMed ID: 1865351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.